Patents by Inventor Kreg A. Zimmern

Kreg A. Zimmern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230012496
    Abstract: Described herein is a beads-free bioprocessor as an automated and cost-effective T cell processing and manufacturing platform. T cells are a core component in CAR T cell therapies for cancer treatment, but are difficult to manufacture to scale in clinically relevant quantities. The 3D bioprocessor provides an alternative device that is scalable, beads-free, easy-to-use, and cost-effective for using CAR T cell therapy in cancer immunotherapy. Besides CAR T cell application, this platform technology has potential for many other applications such as cancer cell isolation.
    Type: Application
    Filed: September 26, 2022
    Publication date: January 19, 2023
    Inventors: Jian Ling, Kreg A. Zimmern, Michael C. Milone
  • Patent number: 11492580
    Abstract: Described herein is a beads-free bioprocessor as an automated and cost-effective T cell processing and manufacturing platform. T cells are a core component in CAR T cell therapies for cancer treatment, but are difficult to manufacture to scale in clinically relevant quantities. The 3D bioprocessor provides an alternative device that is scalable, beads-free, easy-to-use, and cost-effective for using CAR T cell therapy in cancer immunotherapy. Besides CAR T cell application, this platform technology has potential for many other applications such as cancer cell isolation.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: November 8, 2022
    Assignees: Southwest Research Institute, The Trustees of the University of Pennsylvania
    Inventors: Jian Ling, Kreg A. Zimmern, Michael C. Milone
  • Publication number: 20210355420
    Abstract: Described herein is a beads-free bioprocessor as an automated and cost-effective T cell processing and manufacturing platform. T cells are a core component in CAR T cell therapies for cancer treatment, but are difficult to manufacture to scale in clinically relevant quantities. The 3D bioprocessor provides an alternative device that is scalable, beads-free, easy-to-use, and cost-effective for using CAR T cell therapy in cancer immunotherapy. Besides CAR T cell application, this platform technology has potential for many other applications such as cancer cell isolation.
    Type: Application
    Filed: May 12, 2020
    Publication date: November 18, 2021
    Applicants: Southwest Research Institute, The Trustees of the University of Pennsylvania
    Inventors: Jian Ling, Kreg A. Zimmern, Michael C. Milone
  • Publication number: 20170303848
    Abstract: Embodiments of the devices described herein are directed to a vein imaging system which adds user protection, variable positioning, and portability to an established imaging modality, near infrared (NIR) videography and videogrammetry.
    Type: Application
    Filed: April 26, 2017
    Publication date: October 26, 2017
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Kreg Zimmern, Kristen Hamalainen, Andrew Shiels, Sanjiv Patel, Teja Guda